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658a Wednesday, February 29, 2012subunits from the model organism Hydra magnipapillata. These subunits (Hy-
NaC 1-5) form heterotrimeric channels gated directly by endogenous neuropep-
tides. Together with FaNaC, a related ion channel from snails, HyNaCs are the
only known peptide-gated ion channels. Coinjection of HyNaC 2/3/5 in Xeno-
pus oocytes leads to expression of a peptide-gated cation channel with higher
permeability for sodium than for potassium.
Here we show that HyNaC 2/3/5 channels have a substantial permeability for
calcium, which is in the range of the purinergic P2X4 receptor. In Xenopus oo-
cytes, this calcium influx through HyNaC 2/3/5 strongly activates endogenous
calcium-activated chloride channels (CaCCs), leading to a biphasic current.
Blocking of the CaCCs reveals a step-like current without apparent desensiti-
zation. Moreover, we found that calcium permeability of HyNaCs is largely de-
pendent on a single acidic amino acid at the outer entry of the pore region.
Substitution of this acidic residue significantly reduces calcium permeability.
The homologous position has been previously reported to be involved in cal-
cium modulation of the related DEG/ENaC channel ASIC 1a (Paukert 2004).
Collectively, these results suggest that HyNaCs might play an important role
in calcium signalling in vivo.
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Sea anemone venom is a known source of interesting bioactive compounds, in-
cluding peptide toxins which are invaluable tools for studying structure and
function of voltage-gated potassium channels. APETx3 is a novel peptide iso-
lated from the sea anemone Anthopleura elegantissima, containing 42 amino
acids cross-linked by 3 disulfide bridges. Sequence alignment reveals that
APETx3 is a natural occurring mutant from APETx1, only differing in 1 amino
acid at position 3. APETx1 is believed to be a selective modulator of human
ether-a´-go-go related (hERG) potassium channels. In this study, APETx1, 2
and 3 have been subjected to an electrophysiological screening on a wide range
of 21 ion channels expressed in Xenopus leavis oocytes: 10 cloned voltage-
gated sodium channels (NaV1.2-NaV1.8, the insect channels DmNaV1,
BgNaV1-1a and the arachnid channel VdNaV1) and 11 cloned voltage-gated
potassium channels (KV2.1, KV3.1, KV4.2, KV4.3, KV7.1, KV7.2, KV7.3,
KV7.4, KV7.5, hERG, the insect channel Shaker IR). Surprisingly, the Thr3Pro
substitution results in a complete abolishment of APETx3 modulation on hERG
channels. However, the same substitution provides this toxin the ability to be-
come a potent modulator of voltage-gated sodium channels (NaVs). APETx3
slows down the inactivation of mammalian and insect channels similar to
site 3 toxins such as a-scorpion toxins and sea anemone NaVs toxins. Our
screening reveals that the homologous toxins APETx1 and APETx2 display
promiscuous properties as they are also capable of recognizing NaV channels,
causing an inhibition of the sodium conductance.
All together, these data provide new insights in key residues which allow these
toxins to recognize distinct ion channels with similar potency but with different
modulatory effects. Furthermore, we describe for the first time the target pro-
miscuity of a family of sea anemone toxins believed to be highly selective.
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The peptide Discrepin, isolated from the venom of the buthid scorpion Tityus
discrepans, blocks preferentially the IA currents of the voltage-dependent Kþ
channel of rat cerebellum granular cells. There are only six scorpion toxins
known in the sub-family a-KTx15 and Discrepin is the one with the least iden-
tity (approx. 50%) when compared to the others. Furthermore it is the only one
whose action on the blockade of the IA current is irreversible. In order to find
out which residues are important for the blocking effects of discrepin, two mu-
tants were chemically synthesized ([V6K,D20K] and K13deleted), correctly
folded and their physiological properties were examined. Electrophysiological
experiments performed with the double mutant V6K-D20K show that increas-ing the number of positive charges augments the blocking activity: the affinity
for the voltage-dependent Kþ channels increases 10 folds when compared to
the native peptide. Viceversa, the deletion of the lysine residue at position 13
removes the interation of toxin with the channels, confirming the essential
role of positive charges played in channel blockade. Additionally, comparative
analysis of 3D-structure models of the mutants V6K, D20K and V6K-D20K
suggests that probably the N-terminal segment of Discrepin might be the sur-
face implicated in the recognition of the ion-channel.
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Crotamine, a 5KDa peptide possesses a unique biological versatility. Not only
its cell-penetrating activity has become of clinical interest but moreover, its po-
tential selective anti-tumor activity is of great pharmacological importance. Be-
fore, several studies have attempted to elucidate the exact molecular target
responsible for the crotamine-induced skeletal muscle spasm. The aim of this
study was to investigate whether crotamine affects voltage-gated potassium
(KV) channels in an effort to explain its in vivo effects.
Crotamine was studied on ion channel function using the two-electrode voltage
clamp technique on 16 cloned ion channels (12 KV channels and 4 NaV chan-
nels), expressed in Xenopus laevis oocytes.
Crotamine selectively inhibits KV1.1, KV1.2 and KV1.3 channels with an IC50
of ~300 nM and the key amino acids responsible for this molecular interaction
are highlighted. Our results demonstrate for the first time that the symptoms
which are observed in the typical crotamine syndrome may result from the in-
hibition of KV channels.
The ability of crotamine to inhibit the potassium current through KV channels
unravels it as the first snake peptide with the unique multifunctionality such as
cell penetrating, antitumoral activity and KV channel inhibiting properties. The
potent and selective KV channel inhibiting properties, as demonstrated in this
work, can be an advantage for the use of crotamine or its derivatives as anti-
tumor drug. This new property of crotamine might explain some experimental
observations and opens new perspectives of pharmacological uses.
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Obesity is a global health problem and there is a pressing need for safe thera-
peutics. Here, we describe the anti-obesity effects of ShK-186, a Kv1.3-
selective peptide inhibitor with picomolar potency and an excellent safety pro-
file in rodents and monkeys. C57BL/J mice fed a diet containing high fat (21%)
diet and fructose solution (60%) were administered ShK-186 (20, 100 or 500
mg/kg) or vehicle on alternate days by subcutaneous injection. ShK-186-
treatment caused a dose-dependent reduction in weight gain over the 45-day
trial, the maximal weight difference being 30%. ShK-186-treatment reduced
plasma levels of triglyceride and free fatty acids without affecting cholesterol,
HDL, LDL or glucose. CT scan revealed significant reduction in volume of
white adipose tissue (WAT) in ShK-186-treated mice compared to vehicle-
controls. However, histology revealed no difference in cell size and fat content
of white fat cells. In metabolic cage experiments, ShK-186-treatment increased
cumulative intake of food and fluid compared to vehicle-treated mice, espe-
cially during the light-cycle. Furthermore, their respiratory exchange ratio
and energy expenditure were also higher. In PET experiments, ShK-186 treat-
ment increased uptake of 18-fluoro-deoxyglucose (18FDG) by brown adipose
tissue (BAT) and skeletal muscle compared to vehicle-controls; pre-adminis-
tration of the beta-adrenoceptor blocker propranolol (5mg/kg) inhibited
18FDG uptake by BAT but not skeletal muscle. ShK-186’s anti-obesity effect
appears to be mediated by activation of BAT and/or skeletal muscle, two im-
portant thermogenic tissues in the body.
